|1.||Agarwal, Rajesh: 3 articles (06/2010 - 04/2007)|
|2.||Flaig, Thomas W: 2 articles (06/2010 - 04/2007)|
|3.||Su, Lih-Jen: 2 articles (06/2010 - 04/2007)|
|4.||Ismail, Nabila Abd El-fattah: 1 article (06/2014)|
|5.||Darwish, Hebatallah Abd El-moeti: 1 article (06/2014)|
|6.||Ali, Shimaa Omar: 1 article (06/2014)|
|7.||Crawford, E David: 1 article (06/2010)|
|8.||Lucia, M Scott: 1 article (06/2010)|
|9.||Pollak, Michael: 1 article (06/2010)|
|10.||Tao, Yuzhen: 1 article (06/2010)|
|2.||Prostatic Neoplasms (Prostate Cancer)
06/01/2010 - "The purpose of the current trial was to determine the tissue and blood effects of high-dose silybin-phytosome in prostate cancer patients. "
04/01/2007 - "A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients."
04/01/2007 - "We conclude that 13 g of oral silybin-phytosome daily, in 3 divided doses, appears to be well tolerated in patients with advanced prostate cancer and is the recommended phase II dose. "
04/01/2007 - "Silybin-phytosome was administered orally to prostate cancer patients, giving 2.5-20 g daily, in three divided doses. "
06/01/2010 - "A study of high-dose oral silybin-phytosome followed by prostatectomy in patients with localized prostate cancer."
12/01/2008 - "Twenty-week-old TRAMP male mice having palpable prostate tumor were fed with control or 0.5% and 1%, w/w, silybin-phytosome diets for 11 weeks and then sacrificed. "
12/01/2008 - "Herein, for the first time, we investigated the effect and associated mechanisms of silibinin phosphatidylcholine (silybin-phytosome) on established prostate tumors in transgenic adenocarcinoma of the mouse prostate (TRAMP) model. "
|4.||Liver Cirrhosis (Hepatic Cirrhosis)
|2.||Thioctic Acid (Lipoic Acid)
|1.||Prostatectomy (Retropubic Prostatectomy)